WHO director Tedros Adhanom Ghebreyesus visitng Afrigen's facility in Cape Town, where researchers are working on replicating Moderna's shot (Shelley Christians/Reuters via Alamy)
Moderna’s new patent policy is a mixed blessing for WHO effort to replicate company's vaccine
Moderna’s announcement yesterday of a new patent enforcement policy was global, but it had its most immediate impact on one small corner of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
